PrimeGen US, a biotech company developing stem cell therapies, announced February 4 it entered into a definitive business combination agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE